EUVIMEDEUVIMED entdecken
Crossref

Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity

Mallik Greene, Brad Stieber, A Burak Ozbay, Joseph Anderson, Joseph LeMaster, Michael Dore, Igor Stukalin, Jeffrey Arroyo, Derek W Ebner, A Mark Fendrick, Jordan J Karlitz

Journal of the National Comprehensive Cancer Network · 2026-07 · 24 (7)

DOI: 10.6004/jnccn.2026.7015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-07. Verfasst von Mallik Greene und 10 weiteren Autor:innen. Beteiligte Einrichtung: 1Abbott, Madison, WI. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, DNA, Early Detection of Cancer. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fecal immunochemical tests (FITs), fecal occult blood tests (FOBTs), and multitarget stool DNA (mt-sDNA) tests are convenient, noninvasive colorectal cancer (CRC) screening strategies. However, delays in or failure to complete follow-up colonoscopy (FU-CY) after a positive noninvasive test are associated with higher CRC incidence, complications, and mortality. We sought to evaluate FU-CY rates, time to colonoscopy, and compliance predictors. Patients and Methods: This retrospective cohort study linked 2 data sources: Komodo Health Data with Exact Sciences Laboratories. Data were collected from January 2016 to June 2023 and analyzed in 2024. Study participants (ages 45–75 years) were individuals with positive stool-based CRC screening tests (FIT, guaiac-based FOBT, or mt-sDNA tests). FU-CY compliance was assessed at 30-day intervals up to 365 days, and logistic regression was used to identify predictors of FU-CY.

Results

Among 362,646 participants, colonoscopy compliance was 77.1% for mt-sDNA and 45.1% for FIT/FOBT ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColonoscopyColorectal NeoplasmsDNAEarly Detection of CancerFecesAgedFemaleHumansMaleMiddle AgedEthnicityFollow-Up StudiesImmunochemistryMass ScreeningOccult BloodRetrospective StudiesAsianBlack or African American

Substanzen

DNA

Autor:innen und Institutionen

  • 1Abbott, Madison, WI.
  • 2Geisel School of Medicine at Dartmouth, Hanover, NH.
  • 3Kansas University Medical Center, Kansas City, KS.
  • 4Department of Medicine, Duke University, Durham, NC.
  • 5Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
  • 6AltaMed, Los Angeles, CA.

Zitieren

APA

Greene, M., Stieber, B., Ozbay, A. B., Anderson, J., LeMaster, J., Dore, M., Stukalin, I., Arroyo, J., Ebner, D. W., Fendrick, A. M., & Karlitz, J. J. (2026). Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity. Journal of the National Comprehensive Cancer Network, 24(7). https://doi.org/10.6004/jnccn.2026.7015

Vancouver

Greene M, Stieber B, Ozbay AB, Anderson J, LeMaster J, Dore M, et al. Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity. Journal of the National Comprehensive Cancer Network. 2026;24(7). doi:10.6004/jnccn.2026.7015

BibTeX
@article{Greene2026,
  author = {Greene, Mallik and Stieber, Brad and Ozbay, A Burak and Anderson, Joseph and LeMaster, Joseph and Dore, Michael and Stukalin, Igor and Arroyo, Jeffrey and Ebner, Derek W and Fendrick, A Mark and Karlitz, Jordan J},
  title = {Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {7},
  doi = {10.6004/jnccn.2026.7015}
}
Kostenlos starten →